Stock Performance and Market Context
On 28 Nov 2025, National Peroxide's share price touched an intraday low of Rs.515, representing a fall of 3.62% on the day. This decline extends a two-day losing streak, during which the stock has recorded a cumulative return of -6.36%. The current price stands well below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish trend.
In comparison, the broader Sensex index opened flat but gained 0.22% to trade at 85,911.32 points, nearing its 52-week high of 86,055.86. The Sensex's positive momentum was supported by mega-cap stocks and a bullish alignment of its 50-day and 200-day moving averages. National Peroxide's sector, commodity chemicals, however, saw the stock underperform by 3.4% relative to peers on the same day.
Long-Term Price Movement
Over the past year, National Peroxide's stock has declined by 39.45%, contrasting with the Sensex's gain of 8.69% during the same period. The stock's 52-week high was Rs.907.3, indicating a substantial reduction in market valuation. This extended price weakness reflects broader challenges faced by the company within the commodity chemicals industry.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
Financial Metrics and Profitability Trends
National Peroxide's financial indicators reveal subdued performance over recent years. The company’s operating profits have shown a compound annual growth rate (CAGR) of -135.58% over the last five years, indicating a contraction in core earnings. The average EBIT to interest coverage ratio stands at a low 0.14, suggesting limited capacity to comfortably service debt obligations.
Return on equity (ROE) averaged 1.90%, reflecting modest profitability relative to shareholders’ funds. The latest six-month period ending September 2025 reported a profit after tax (PAT) of Rs.1.28 crore, which represents a decline of 77.78% compared to the prior period. Additionally, non-operating income accounted for 263.49% of profit before tax (PBT) in the quarter, highlighting reliance on income sources outside core operations.
Valuation and Risk Considerations
The stock’s valuation metrics indicate elevated risk relative to historical averages. Over the past year, profits have fallen by 113%, while the stock price has declined by 39.45%. This disparity points to challenges in translating earnings performance into market valuation. National Peroxide has also underperformed the BSE500 index across multiple time frames, including the last three years, one year, and three months, underscoring persistent underperformance relative to a broad market benchmark.
Shareholding and Market Position
The majority shareholding of National Peroxide remains with promoters, maintaining concentrated ownership. The company operates within the commodity chemicals sector, which has experienced varied market dynamics in recent periods. Despite the broader market’s positive trend, National Peroxide’s stock has not aligned with sector or index gains.
Is National Peroxide your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Summary of Current Market Standing
National Peroxide’s stock performance at Rs.515 marks a significant milestone as it reaches its lowest level in 52 weeks and all-time lows. The stock’s decline contrasts with the broader market’s upward momentum, as the Sensex trades near its yearly peak. The company’s financial data points to subdued profitability, weak debt servicing capacity, and a contraction in operating profits over recent years.
While the commodity chemicals sector continues to evolve, National Peroxide’s share price and earnings trajectory reflect ongoing challenges in aligning with sectoral and market trends. The stock’s position below all major moving averages further emphasises the prevailing downtrend in price action.
Market Outlook and Considerations
Investors and market participants observing National Peroxide will note the stock’s extended period of underperformance relative to key indices and sector peers. The company’s financial metrics suggest a cautious approach to its current valuation and earnings profile. The stock’s recent price action, including the 3.62% decline on 28 Nov 2025 and the two-day cumulative fall of 6.36%, highlights the prevailing market sentiment.
National Peroxide’s share price remains substantially below its 52-week high of Rs.907.3, underscoring the scale of the correction experienced over the past year. The company’s ability to generate returns on equity and service debt remains limited, as reflected in the latest financial disclosures.
Conclusion
National Peroxide’s fall to Rs.515, its 52-week low, encapsulates a period of sustained price weakness amid challenging financial conditions. The stock’s performance diverges from the broader market’s positive trend, with key financial indicators signalling subdued profitability and elevated risk. The company’s position within the commodity chemicals sector and its concentrated promoter ownership remain notable factors in its market profile.
Get 1 year of Weekly Picks FREE when you subscribe to MojoOne. Offer ends soon. Start Saving Now →
